Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Emerald Bioscience Inc (EMBI)

Emerald Bioscience Inc (EMBI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 24,127
  • Shares Outstanding, K 268,074
  • Annual Sales, $ 0 K
  • Annual Income, $ 1,050 K
  • 60-Month Beta 0.43
  • Price/Sales N/A
  • Price/Cash Flow 1.08
  • Price/Book N/A
Trade EMBI with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.02
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 12/31/20
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0327 +175.23%
on 12/16/20
0.1195 -24.69%
on 01/13/21
+0.0562 (+166.27%)
since 12/15/20
3-Month
0.0245 +267.35%
on 12/09/20
0.1195 -24.69%
on 01/13/21
+0.0480 (+114.29%)
since 10/15/20
52-Week
0.0245 +267.35%
on 12/09/20
0.2000 -55.00%
on 02/05/20
-0.0900 (-50.00%)
since 01/15/20

Most Recent Stories

More News
Skye Bioscience Appoints Cannabinoid Science Experts Giovanni Appendino, PhD and Eduardo Muñoz, MD, PhD to Scientific Advisory Board

San Diego, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived...

EMBI : 0.0900 (+1.69%)
SKYE : 13.00 (+1.17%)
Skye Bioscience to Present at H.C. Wainwright Global Life Sciences Conference

San Diego, Calif., March 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived...

EMBI : 0.0900 (+1.69%)
SKYE : 13.00 (+1.17%)
Skye Bioscience to Participate in Investment Conferences in February

San Diego, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (OTCQB: SKYE) (“SKYE” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived...

EMBI : 0.0900 (+1.69%)
SKYE : 13.00 (+1.17%)
Emerald Bioscience Launches Rebrand Including Name Change to Skye Bioscience

Name change reflects Company’s evolution, renewed team and strategic focus on advancing its lead compound into human trials Company to trade under ticker SKYE effective January 19, 2021

EMBI : 0.0900 (+1.69%)
SKYE : 13.00 (+1.17%)
Emerald Bioscience to Change Name and Trading Symbol Effective Tuesday, January 19th

San Diego, Calif, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“EMBI” or the “Company”), a biopharmaceutical company focused on developing proprietary, synthetic cannabinoid-derived...

EMBI : 0.0900 (+1.69%)
Emerald Bioscience to Present at the KCSA Cannabis Investor Conference

San Diego, Calif, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a biopharmaceutical company focused on developing differentiated, proprietary...

EMBI : 0.0900 (+1.69%)
Emerald Bioscience Reports that Superior Reduction of Intraocular Pressure of its Unique Nanoemulsion Formulation of THCVHS is Published in Peer-Reviewed Journal

Drug Delivery and Translational Research article highlights significantly better drug load and duration of activity of prodrug of THC compared to leading commercial drugs for treating glaucoma

EMBI : 0.0900 (+1.69%)
Emerald Bioscience to Present at the Benzinga Global Small Cap Virtual Conference

San Diego, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald” or the “Company”), a preclinical-stage biopharmaceutical company focused on developing proprietary...

EMBI : 0.0900 (+1.69%)
Emerald Bioscience Provides Corporate Update

Renewed team and capital focused on advancing lead compound for glaucoma into human studies

EMBI : 0.0900 (+1.69%)
Emerald Bioscience to Present at the H.C. Wainwright 22nd Annual Global Investment Conference

San Diego, CA, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Emerald Bioscience, Inc. (OTCQB: EMBI a preclinical-stage biopharmaceutical company focused on the development of proprietary first-in-class molecules...

EMBI : 0.0900 (+1.69%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Emerald Bioscience Inc. is a biopharmaceutical company. It is focused on the discovery, development, and commercialization of bioengineered cannabinoid-based therapeutics for unmet medical needs. The company's product pipeline consists of NB1111, NB2222 and NB3000 which are in clinical stage. Emerald...

See More

Key Turning Points

3rd Resistance Point 0.1093
2nd Resistance Point 0.1047
1st Resistance Point 0.0973
Last Price 0.0900
1st Support Level 0.0853
2nd Support Level 0.0807
3rd Support Level 0.0733

See More

52-Week High 0.2000
Fibonacci 61.8% 0.1330
Fibonacci 50% 0.1123
Fibonacci 38.2% 0.0915
Last Price 0.0900
52-Week Low 0.0245

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar